Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;178(2):151-164.
doi: 10.1002/ajmg.c.31614. Epub 2018 May 15.

Nongenetic risk factors for holoprosencephaly: An updated review of the epidemiologic literature

April D Summers  1 , Jennita Reefhuis  1 , Joanna Taliano  2 , Sonja A Rasmussen  3
Affiliations
Review

Nongenetic risk factors for holoprosencephaly: An updated review of the epidemiologic literature

April D Summers et al. Am J Med Genet C Semin Med Genet. 2018 Jun.

Abstract

Holoprosencephaly (HPE) is a major structural birth defect of the brain that occurs in approximately 1 in 10,000 live births. Although some genetic causes of HPE are known, a substantial proportion of cases have an unknown etiology. Due to the low birth prevalence and rarity of exposure to many potential risk factors for HPE, few epidemiologic studies have had sufficient sample size to examine risk factors. A 2010 review of the literature identified several risk factors that had been consistently identified as occurring more frequently among cases of HPE, including maternal diabetes, twinning, and a predominance of females, while also identifying a number of potential risk factors that had been less widely studied. In this article, we summarize a systematic literature review conducted to update the evidence for nongenetic risk factors for HPE.

Keywords: cyclopia; diabetes; holoprosencephaly; sex ratio; twinning.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None.

Figures

FIGURE 1
FIGURE 1
Search strategy for identifying epidemiologic studies of nongenetic risk factors of holoprosencephaly since the 2010 review was conducted. * Johnson and Rasmussen (2010)
See this image and copyright information in PMC

References

    1. Anderson JL, Waller DK, Canfield MA, Shaw GM, Watkins ML, & Werler MM (2005). Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology, 16(1), 87–92. 10.1097/01.ede.0000147122.97061.bb - DOI - PubMed
    1. Berry SM, Gosden C, Snijders RJ, & Nicolaides KH (1990). Fetal holoprosencephaly: Associated malformations and chromosomal defects. Fetal Diagnosis and Therapy, 5(2), 92–99. 10.1159/000263552 - DOI - PubMed
    1. Billington CJ Jr., Schmidt B, Marcucio RS, Hallgrimsson B, Gopalakrishnan R, & Petryk A (2015). Impact of retinoic acid exposure on midfacial shape variation and manifestation of holoprosencephaly in Twsg1 mutant mice. Disease Models & Mechanisms, 8(2), 139–146. 10.1242/dmm.018275 - DOI - PMC - PubMed
    1. Browne ML, Rasmussen SA, Hoyt AT, Waller DK, Druschel CM, Caton AR, … Romitti PA (2009). Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Research Part A: Clinical and Molecular Teratology, 85(7), 621–628. 10.1002/bdra.20573 - DOI - PMC - PubMed
    1. Bullen PJ, Rankin JM, & Robson SC (2001). Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. American Journal of Obstetrics and Gynecology, 184 (6), 1256–1262. 10.1067/mob.2001.111071 - DOI - PubMed

LinkOut - more resources